TransMedics Cancels IPO

TransMedics Inc., an Andover, Mass.-based developer of portable life support systems for organ transplants, has withdrawn its registration for an $86.25 million IPO, citing “market conditions.” It haad planned to trade on the Nasdaq under ticker symbol TMDX, with Morgan Stanley serving as lead underwriter.

The company has raised around $90 million in total VC funding since 2000, including a $25.5 million Series D round earlier this year. Shareholders include 3i Group (24.4% stake), Tudor Investment Corp. (14.7%), Flagship Ventures (14.3%), VantagePoint Venture Partners (10%), Sherbrooke Partners (9.2%), Alta Partners (8.9%), CB Health Ventures (7.4%), Posco BioVentures and Sagamore Bioventures. www.transmedics.com

Related Posts

Leave a Reply

PEHUB Community

Join the 12493 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups